What does CARDIOSURGICALE do?

CARDIOSURGICALE is a general practice in Gesves. Private Limited, started on 24 December 2002.

What is the address of CARDIOSURGICALE?

The registered office of CARDIOSURGICALE is located at Rue de Bounon 2, 5340 Gesves.

Is CARDIOSURGICALE still active?

Yes. According to the CBE (30 October 2026) CARDIOSURGICALE is active, legal situation “Normale toestand”, started on 24 December 2002.

Is CARDIOSURGICALE registered on Peppol?

Yes, CARDIOSURGICALE is registered on the Peppol network with ID 0208:0479133577.

What is the enterprise number of CARDIOSURGICALE?

The enterprise number of CARDIOSURGICALE is BE0479133577.

When was CARDIOSURGICALE founded?

CARDIOSURGICALE was founded on 24 December 2002.

Who are the directors of CARDIOSURGICALE?

According to the 2025 annual accounts, the directors of CARDIOSURGICALE are: Pierre-Yves ETIENNE.

Is CARDIOSURGICALE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CARDIOSURGICALE make in 2025?

CARDIOSURGICALE posted a profit after taxes of € 105,571 in financial year 2025.

What is the revenue of CARDIOSURGICALE?

As a small company, CARDIOSURGICALE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 147,606.

CARDIOSURGICALE (Private Limited) - Gesves - BE0479133577

Dossier CARDIOSURGICALE, printed on 30 October 2026 from databakkes.be/en/0479133577/cardiosurgicale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CARDIOSURGICALE from Gesves, company number BE0479133577, closed financial year 2025 with a result of € 105,571 after tax. For that financial year CARDIOSURGICALE recorded a gross margin of € 147,606 and equity of € 335,403. Compared with financial year 2024, the result moved from € 62,462 to € 105,571. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Healthy

€ 335,403

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 105,571

▲ 69% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 47,646

▼ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,372 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 110,086

▲ € 94,322 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,418

▼ 45% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 30,991

▲ € 24,991 vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	€ 413,424 Revenue 2024: € 413,424 First fiscal year in the series	-
Gross margin	€ 166,681 Gross margin 2022: € 166,681 First fiscal year in the series	€ 80,512 Gross margin 2023: € 80,512 ▼ 52% vs 2022 (€ 166,681) Unfavourable step	€ 93,443 Gross margin 2024: € 93,443 ▲ 16% vs 2023 (€ 80,512) Favourable step	€ 147,606 Gross margin 2025: € 147,606 ▲ 58% vs 2024 (€ 93,443) Favourable step	▲ 58%
Profit after taxes	€ 112,742 Profit after taxes 2022: € 112,742 First fiscal year in the series	€ 54,626 Profit after taxes 2023: € 54,626 ▼ 52% vs 2022 (€ 112,742) Unfavourable step	€ 62,462 Profit after taxes 2024: € 62,462 ▲ 14% vs 2023 (€ 54,626) Favourable step	€ 105,571 Profit after taxes 2025: € 105,571 ▲ 69% vs 2024 (€ 62,462) Favourable step	▲ 69%
Equity	€ 373,283 Equity 2022: € 373,283 First fiscal year in the series	€ 386,849 Equity 2023: € 386,849 ▲ 4% vs 2022 (€ 373,283) Favourable step	€ 350,204 Equity 2024: € 350,204 ▼ 9% vs 2023 (€ 386,849) Unfavourable step	€ 335,403 Equity 2025: € 335,403 ▼ 4% vs 2024 (€ 350,204) Unfavourable step	▼ 4%
Total debts	€ 38,827 Total debts 2022: € 38,827 First fiscal year in the series	€ 59,714 Total debts 2023: € 59,714 ▲ 54% vs 2022 (€ 38,827) Unfavourable step	€ 110,393 Total debts 2024: € 110,393 ▲ 85% vs 2023 (€ 59,714) Unfavourable step	€ 160,426 Total debts 2025: € 160,426 ▲ 45% vs 2024 (€ 110,393) Unfavourable step	▲ 45%
Cash	€ 213,180 Cash 2022: € 213,180 First fiscal year in the series	€ 229,839 Cash 2023: € 229,839 ▲ 8% vs 2022 (€ 213,180) Favourable step	€ 108,829 Cash 2024: € 108,829 ▼ 53% vs 2023 (€ 229,839) Unfavourable step	€ 47,646 Cash 2025: € 47,646 ▼ 56% vs 2024 (€ 108,829) Unfavourable step	▼ 56%
Retained profit	€ 360,883 Retained profit 2022: € 360,883 First fiscal year in the series	€ 374,449 Retained profit 2023: € 374,449 ▲ 4% vs 2022 (€ 360,883) Favourable step	€ 350,203 Retained profit 2024: € 350,203 ▼ 6% vs 2023 (€ 374,449) Unfavourable step	€ 335,402 Retained profit 2025: € 335,402 ▼ 4% vs 2024 (€ 350,203) Unfavourable step	▼ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 41,060 Dividend 2023: € 41,060 Unchanged (€ 0) Unchanged	€ 86,708 Dividend 2024: € 86,708 ▲ 111% vs 2023 (€ 41,060) Unchanged	€ 120,372 Dividend 2025: € 120,372 ▲ 39% vs 2024 (€ 86,708) Unchanged	▲ 39%
Balance sheet total	€ 412,109 Balance sheet total 2022: € 412,109 First fiscal year in the series	€ 446,563 Balance sheet total 2023: € 446,563 ▲ 8% vs 2022 (€ 412,109) Unchanged	€ 460,597 Balance sheet total 2024: € 460,597 ▲ 3% vs 2023 (€ 446,563) Unchanged	€ 495,829 Balance sheet total 2025: € 495,829 ▲ 8% vs 2024 (€ 460,597) Unchanged	▲ 8%

Key figures of CARDIOSURGICALE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CARDIOSURGICALE?

What happened at CARDIOSURGICALE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 11, 2026 New annual accounts for financial year 2025: profit of € 105,571 (▲ 69% vs 2024). Source: NBB ↗
Dec 24, 2002 Start of the company according to the CBE. KBO
2002 Pierre-Yves ETIENNE became a director. NBB

In short

From € 112,742 profit in 2022 to € 105,571 profit in 2025.

Paid € 137,124 in corporate taxes since 2022.

Best year ever: 2022, with € 112,742 profit.

Paid out € 248,140 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Pierre-Yves ETIENNE

CARDIOSURGICALE

Behind CARDIOSURGICALE is Pierre-Yves ETIENNE.

Directors

According to the 2025 annual accounts

Pierre-Yves ETIENNE

Administrator-manager

since 2002

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Bounon 2

5340 Gesves

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

NEURO CR

€ 89,123 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0479.133.577
VAT number: BE 0479.133.577
Registered office: Rue de Bounon 2, 5340 Gesves
Names & denominations: CARDIOSURGICALE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 December 2002
Peppol: Active · Active since 17 Feb 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗